NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
school
University Rankings
subject
University Subject Rankings
place
Country Rankings
insights
i10 Productivity Rankings
insights
Subject Rankings
format_list_numbered
Top 100 Scientists
format_list_numbered
Citation Rankings
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
James Monn
AD Scientific Index 2024
Natural Sciences / Chemical Sciences
Karuna Therapeutics - / United States
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
James Monn's MOST POPULAR ARTICLES
1-)
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial ST Patil, L Zhang, F Martenyi, SL Lowe, KA Jackson, BV Andreev, ... Nature medicine 13 (9), 1102-1107, 2007 12472007
2-)
Pharmacological agents acting at subtypes of metabotropic glutamate receptors DD Schoepp, DE Jane, JA Monn Neuropharmacology 38 (10), 1431-1476, 1999 12271999
3-)
Metabotropic glutamate receptors as novel targets for anxiety and stress disorders CJ Swanson, M Bures, MP Johnson, AM Linden, JA Monn, DD Schoepp Nature reviews Drug discovery 4 (2), 131-144, 2005 7032005
4-)
Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo [3.1. 0] hexane-2, 6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 …JA Monn, MJ Valli, SM Massey, RA Wright, CR Salhoff, BG Johnson, ...Journal of medicinal chemistry 40 (4), 528-537, 19974771997
5-)
Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptorsDR Helton, JP Tizzano, JA Monn, DD Schoepp, MJ KallmanJournal of Pharmacology and Experimental Therapeutics 284 (2), 651-660, 19983501998
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept